Cellular Immunotherapy Division

Verified Pharmaceutical Manufacturer & Oncology Drug Supplier

Back to Pharmaceuticals Directory

Cellular Immunotherapy Division

Verified Partner

Registered pharmaceutical manufacturer and healthcare technology supplier listed on the ONC-ORG national directory.

Company Profile & Registration

Legal Organization NameCellular Immunotherapy Division

Manufacturer Identification CodeRegistered

Authorized RepresentativeCorporate Representative

Compliance & StatusActive / Listed

Oncology Drugs & Clinical Formulations

Featured Drug Formulation

Obecabtagene Autoleucel

Generic: Obecabtagene Autoleucel

Class: Autologous CAR T-Cell Immunotherapy

View Complete Drug Profile

Indications: Relapsed or refractory B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Mantle Cell Lymphoma, or Multiple Myeloma.

Direct Communication & Assistance

Send an Inquiry to Cellular Immunotherapy Division

Our oncology navigation desk will route your inquiry regarding medicine access, clinical partnerships, or product availability to the appropriate representative.